High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients

• Hirokazu Honda ,

  * E-mail: hondah@med.showa-u.ac.jp

  Affiliations Showa University Koto Toyosu Hospital, Division of Nephrology, Department of Medicine, Tokyo, Japan, Showa University, School of Medicine, Division of Nephrology, Department of Medicine, Tokyo, Japan

  http://orcid.org/0000-0002-5634-6145

  ⨯
• Tetsuo Michihata,

  Affiliation Ebara Clinic, Department of Dialysis, Tokyo, Japan

  ⨯
• Kanji Shishido,

  Affiliation Kawasaki Clinic, Department of Dialysis, Kawasaki, Japan

  ⨯
• Keiko Takahashi,

  Affiliation Division of Dialysis, Kitami Higashiyama Clinic, Tokyo, Japan

  ⨯
• Go Takahashi,

  Affiliation Showa University Northern Yokohama Hospital, Department of Internal Medicine, Yokohama, Japan

  ⨯
• Nozomu Hosaka,

  Affiliations Showa University Koto Toyosu Hospital, Division of Nephrology, Department of Medicine, Tokyo, Japan, Showa University, School of Medicine, Division of Nephrology, Department of Medicine, Tokyo, Japan

  ⨯
• Misa Ikeda,

  Affiliation Showa University, School of Medicine, Division of Nephrology, Department of Medicine, Tokyo, Japan

  ⨯
• Daisuke Sanada,

  Affiliation Showa University, School of Medicine, Division of Nephrology, Department of Medicine, Tokyo, Japan

  ⨯
• Takanori Shibata

  Affiliation Showa University Northern Yokohama Hospital, Department of Internal Medicine, Yokohama, Japan

  ⨯